Host: Andrea Singer, MD, FACP, CCD

Guest: Paul A. Anderson, MD

Guest: Susan V. Bukata, MD, FAOA, FAAOS

Since the recording of this CME activity, the following updates have been published:

• NAMS Position Statement on the Management of Osteoporosis in Postmenopausal Women
  • Menopause. 2021;28(9):973-997.

• Consensus Statement from the Bone Health and Osteoporosis Foundation, formerly known as the National Osteoporosis Foundation
  • The Clinician’s Guide to Prevention and Treatment of Osteoporosis. Osteoporosis Int. 2022;33(10):2049-2102.

While there’s growing awareness among orthopedic surgeons that osteoporosis is the underlying cause of fractures, there is often a disconnect between this recognition and action in the form of treatment to prevent subsequent fractures. In this discussion, Drs. Andrea Singer, Paul Anderson, and Susan Bukata address the pathophysiology of osteoporosis and the need to identify patients at risk for additional fractures. Osteoporosis treatment (including pharmacotherapy) can play a critical role in preventing future fractures, but physicians must first recognize that fracture is a sentinel event and treat it as a call to action.